Ahmet Ayav, Nagy Habib, Long R Jiao. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Adenocarcinoma/secondaryAdenocarcinoma/therapyAdultAntineoplastic Agents/administration & dosageAntineoplastic Combined Chemotherapy Protocols/therapeutic useCapecitabineDeoxycytidine/administration & dosageDeoxycytidine/analogs & derivativesFluorouracil/administration & dosageHepatectomyHumansHypertension, Portal/chemically inducedLiver Neoplasms/secondaryLiver Neoplasms/therapyMaleMicrospheresOrganoplatinum Compounds/administration & dosageOxaliplatinRadiopharmaceuticals/adverse effectsYttrium Radioisotopes/adverse effects
Substances: See more » Antineoplastic AgentsOrganoplatinum CompoundsRadiopharmaceuticalsYttrium RadioisotopesOxaliplatinDeoxycytidineCapecitabineFluorouracil
Year: 2005 PMID: 16278485 DOI: 10.1200/JCO.2005.03.7820
Source DB: PubMed Journal: J Clin Oncol ISSN: 0732-183X Impact factor: 44.544